Загрузка...
Nanoencapsulated rituximab mediates superior cellular immunity against metastatic B-cell lymphoma in a complement competent humanized mouse model
BACKGROUND: Despite the numerous applications of monoclonal antibodies (mAbs) in cancer therapeutics, animal models available to test the therapeutic efficacy of new mAbs are limited. NOD.Cg-Prkdc(scid) Il2rg(tm1Wjl)/SzJ (NSG) mice are one of the most highly immunodeficient strains and are universal...
Сохранить в:
| Опубликовано в: : | J Immunother Cancer |
|---|---|
| Главные авторы: | , , , , , , , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
BMJ Publishing Group
2021
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7888328/ https://ncbi.nlm.nih.gov/pubmed/33593826 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/jitc-2020-001524 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|